Topics
Insights on the global economy, markets and topics related to our business.
Latest
The Road Ahead for COVID-19 Vaccines
With one or more COVID-19 vaccines on the horizon, investors are looking ahead to the manufacturing and distribution of the vaccine. During a recent daily Goldman Sachs Asset Management (GSAM) Forum event, Dr. John Grabenstein, president of consulting service Vaccine Dynamics SP and former Global Executive Director of Medical Affairs for Merck Vaccines, discussed the logistics of a vaccine rollout with Gurpreet Gill, a macro strategist within GSAM’s Fixed Income team.
Asia-Pacific Economic Outlook for 2021
Andrew Tilton, chief Asia-Pacific economist for Goldman Sachs Research, talks about his team’s economic outlook for Asia-Pacific in 2021, and why they’re forecasting above-consensus growth.
US Holiday Retail Outlook
Kate McShane of Goldman Sachs Research talks about how the pandemic has changed consumer spending habits and what it all means for the US retail market this holiday season.
Markets Update: The Bull Run in 2021
Peter Oppenheimer, the firm’s chief global equity strategist, talks about why his team remains confident about the global recovery in 2021.
How Technology is Disrupting the Insurance Industry
Kelly Galanis, head of the Americas Financial Technology sector in the Investment Banking Division, explains how insurtechs are disrupting the insurance industry.
What’s Next for the U.S. Dollar
Ricardo Mora, co-head of Americas FICC Sales, explains the factors driving the weaker U.S. dollar and how the currency stacks up against other major developed and emerging market currencies.